Scientific Reports · 2020 · 16 citations · 26 references
Life SciencesGeneticsMolecular GeneticsGenetic EpidemiologyHuman GeneticsPharmacogeneticsDrug Metabolism GeneticsPopulation PharmacogeneticsAdverse Drug ResponseCyp2c9 GenotypingCytochrome P450 Genetic PolymorphismCytochrome P450 GenotypingDrug Metabolism PolymorphismsInformed ConsentPharmacogenetic Variant Frequencies
Genetic variation in cytochrome P450 (CYP) 2C9 is known to cause significant inter-individual differences in drug response and adverse effects. The frequencies of CYP2C9*2 and CYP2C9*3, both of which are responsible for the low activity of the enzyme, are not known in the Pakistani population. Therefore, we screened various ethnic groups residing in Pakistan for these polymorphisms. A total of 467 healthy human volunteers were recruited from six major ethnicities of Pakistan after written informed consent. Our results indicate that about 20% of the Pakistani population has a genotype containing at least one low activity allele. Ethnic Punjabi and Pathan populations had the highest frequencies of wild type genotypes while Urdu, Seraiki, and Sindhi populations showed higher rates of both low activity genotypes. The Baloch population showed the highest rates of low activity genotypes with less than 50% of the samples showing wild type genotypes, suggesting that more than half of the Baloch population possesses low activity genotypes. The frequencies found in various ethnic groups in Pakistan were comparable with ethnicities in the South Asian region except for the Baloch population. These results suggest that pharmacogenetics screening for low activity genotypes may be a helpful tool for clinicians while prescribing medications metabolized by CYP2C9.
26
A global reference for human genetic variation
Richard Durbin, Peter Donnelly, Paul Flicek et al. · Nature · 2015 · 20K citations · Full text
Insights into human genetic variation and population history from 929 diverse genomes
Anders Bergström, Shane McCarthy, Ruoyun Hui et al. · Science · 2020 · 1.1K citations · Full text
THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
Mary F. Paine, Heather L. Hart, Shana S. Ludington et al. · Drug Metabolism and Disposition · 2006 · 874 citations
Medicine, Biochemistry, Pharmacology +12
The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
Theresa H. Sullivan-Klose, Burhan I. Ghanayem, Douglas A. Bell et al. · Pharmacogenetics · 1996 · 587 citations
Medicine, Genetics, Pharmacology +17
Genetic analysis of the human cytochrome P450 CYP2C9 locus
Michael J. Stubbins, Lorna W. Harries, Gillian Smith et al. · Pharmacogenetics · 1996 · 303 citations
Medicine, Genetics, Pharmacology +14